BioChange specializes in tissue regeneration technology and is the developer of CellFoam, an injectable scaffold that stimulates tissue repair and remodeling at the site of injection.

Based on natural biomaterials designed for implantation using a minimally invasive procedure, the scaffold mimics the healthy extra-cellular matrix and triggers the body to repair itself.CellFoams bio-adhesive 3D foam structure starts out as flowable and solidifies within the target tissue, transforming into a functional tissue graft.

It is made of natural materials and is fully biocompatible, biodegradable, and rich with cellular adhesion sites (RGD motifs), making it an ideal scaffold for stimulating cell growth.

The technology has demonstrated long-term safety and efficacy in preclinical studies and is successfully used to treat urinary incontinence in female dogs.

Several other products based on the CellFoam platform technology are in development.

BioChange has conducted multiple long-term animal studies that have confirmed the safety and efficacy of its technology.

The company is currently selling products in the veterinary market and is focused on starting a clinical study in aesthetic dermatology.